Stay updated on SubQ Efgartigimod in CIDP Clinical Trial
Sign up to get notified when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.

Latest updates to the SubQ Efgartigimod in CIDP Clinical Trial page
- Check7 days agoChange DetectedRevision updated to v3.5.2. Previous revision v3.5.0 was removed.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedCIDP is added as a listed condition, and a Genetic and Rare Diseases Information Center resource link is included.SummaryDifference0.1%

- Check36 days agoChange Detected- Added Naples, Italy 80131 and removed Napoli, Italy 80131 from the locations list. - Publication section updated with the Lancet Neurology ADHERE study citation and DOI; Revision updated to v3.5.0.SummaryDifference0.1%

- Check50 days agoChange DetectedFooter revision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check65 days agoChange DetectedPublications section now includes the Lancet Neurology ADHERE publication citation. The previous citation entry was removed.SummaryDifference0.0%

- Check72 days agoChange DetectedRevision: v3.4.2 appears as a minor metadata update with no impact on study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to SubQ Efgartigimod in CIDP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SubQ Efgartigimod in CIDP Clinical Trial page.